The biological basis of headache

References

• Stovner LJ, Hagen K, Jensen R et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia27(3), 193–210 (2007).
   PubMed Web of Science ®Google Scholar
• Ray BS, Wolff HG. Experimental studies on headache. Pain sensitive structures of the head and their significance in headache. Arch. Surg.41, 813–856 (1940).
   Google Scholar
• Wolff HG. Headache and Other Head Pain. Oxford University Press, NY, USA (1963).
   Google Scholar
• McNaughton FL. The innervation of the intracranial blood vessels and the dural sinuses. In: The Circulation of the Brain and Spinal Cord. Cobb S, Frantz AM, Penfield W, Riley HA (Eds). Hafner Publishing Co., NY, USA, 178–200 (1966).
   Google Scholar
• Arbab MAR, Wiklund L, Svendgaard NA. Origin and distribution of cerebral vascular innervation from superior cervical, trigeminal and spinal ganglia investigated with retrograde and anterograde WGA-HRP tracing in the rat. Neuroscience19, 695–708 (1986).
   PubMed Web of Science ®Google Scholar
• Knight YE, Bartsch T, Goadsby PJ. Trigeminal antinociception induced by bicuculline in the periaqueductal grey (PAG) is not affected by PAG P/Q-type calcium channel blockade in rat. Neurosci. Lett.336, 113–116 (2003).
   PubMed Web of Science ®Google Scholar
• Uddman R, Edvinsson L, Ekman R, Kingman T, McCulloch J. Innervation of the feline cerebral vasculature by nerve fibers containing calcitonin gene-related peptide: trigeminal origin and co-existence with substance P. Neurosci. Lett.62, 131–136 (1985).
   PubMed Web of Science ®Google Scholar
• Goadsby PJ, Zagami AS, Lambert GA. Neural processing of craniovascular pain: a synthesis of the central structures involved in migraine. Headache31(6), 365–371 (1991).
   PubMed Web of Science ®Google Scholar
• Kemplay S, Webster KE. A quantitative study of the projections of the gracile, cuneate and trigeminal nuclei and of the medullary reticular formation to the thalamus in the rat. Neuroscience32(1), 153–167 (1989).
   PubMed Web of Science ®Google Scholar
• Gebhart GF, Sandkühler J, Thalhammer JG, Zimmermann M. Inhibition in spinal cord of nociceptive information by electrical stimulation and morphine microinjection at identical sites in midbrain of the cat. J. Neurophysiol.51(1), 75–89 (1984).
   PubMed Web of Science ®Google Scholar
• Hosobuchi Y, Adams JE, Linchitz R. Pain relief by electrical stimulation of the central gray matter in humans and its reversal by naloxone. Science197(4299), 183–186 (1977).
   PubMed Web of Science ®Google Scholar
• McMahon SB, Wall PD. Descending excitation and inhibition of spinal cord lamina I projection neurons. J. Neurophysiol.59(4), 1204–1219 (1988).
   PubMed Web of Science ®Google Scholar
• Sandkühler J. The organization and function of endogenous antinociceptive systems. Prog. Neurobiol.50(1), 49–81 (1996).
   PubMed Web of Science ®Google Scholar
• Reynolds DV. Surgery in the rat during electrical analgesia induced by focal brain stimulation. Science164, 444–445 (1969).
   PubMed Web of Science ®Google Scholar
• Weiller C, May A, Limmroth V et al. Brain stem activation in spontaneous human migraine attacks. Nat. Med.1(7), 658–660 (1995).
   PubMed Web of Science ®Google Scholar
• Goadsby PJ. Neurovascular headache and a midbrain vascular malformation: evidence for a role of the brainstem in chronic migraine. Cephalalgia22, 107–111 (2002).
   PubMed Web of Science ®Google Scholar
• Gee JR, Chang J, Dublin AB, Vijayan N. The association of brainstem lesions with migraine-like headache: an imaging study of multiple sclerosis. Headache45(6), 670–677 (2005).
   PubMed Web of Science ®Google Scholar
• Burstein R, Levy D, Jakubowski M, Woolf CJ. Peripheral and central sensitization related to headaches. In: The Headaches 3rd Edition. Olesen J, Goadsby PJ, Ramadan N, Tfelt-Hansen P, Welch KMA (Eds). Lippincott Williams and Wilkins, PA, USA, 121–129 (2006).
   Google Scholar
• Strassman AM, Raymond SA, Burstein R. Sensitization of meningeal sensory neurons and the origin of headaches. Nature384, 560–564 (1996).
   PubMed Web of Science ®Google Scholar
• Bolay H, Reuter U, Dunn AK et al. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat. Med.8, 136–142 (2002).
   PubMed Web of Science ®Google Scholar
• Waeber C, Moskowitz MA. Migraine as an inflammatory disorder. Neurology64, S9–S15 (2005).
   PubMed Web of Science ®Google Scholar
• McCulloch J, Uddman R, Kingman TA et al. Calcitonin gene-related peptide: functional role in cerebrovascular regulation. Proc. Natl Acad. Sci. USA83, 5731–5735 (1986).
   PubMed Web of Science ®Google Scholar
• Edvinsson L, Ekman R, Jansen I et al, Calcitonin gene-related peptide and cerebral blood vessels: distribution and vasomotor effects. J. Cereb. Blood Flow Metab.7, 720–728 (1987).
   PubMed Web of Science ®Google Scholar
• Markowitz S, Saito K, Moskowitz MA. Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain. J. Neurosci.7, 4129–4136 (1987).
   PubMed Web of Science ®Google Scholar
• Shepheard SL, Williamson DJ, Hill RG. The non-peptide neurokinin1 receptor antagonist, RP 67580, blocks neurogenic plasma extravasation in the dura mater of rats. Br. J. Pharmacol.108(1), 11–12 (1993).
   PubMed Web of Science ®Google Scholar
• Kurosawa M, Messlinger K, Pawlak M, Schmidt RF. Increase of meningeal blood flow after electrical stimulation of rat dura mater encephali: mediation by calcitonin gene-related peptide. Br. J. Pharmacol.114(7), 1397–1402 (1995).
   PubMed Web of Science ®Google Scholar
• Carmody J, Pawlak M, Messlinger K. Lack of a role for substance P in the control of dural arterial flow. Exp. Brain Res.111(3), 424–428 (1996).
   PubMed Web of Science ®Google Scholar
• Watkins L, Maier S. Beyond neurons: evidence that immune and glial cells contribute to pathological pain states. Physiol. Rev.82, 981–1011 (2002).
   PubMed Web of Science ®Google Scholar
• Hanani M. Satellite glial cells in sensory ganglia: from form to function. Brain Res. Brain Res. Rev.48, 457–476 (2005).
   PubMedGoogle Scholar
• Watkins L, Milligan E, Maier S. Glial activation: a driving force for pathological pain. Trends Neurosci.24, 450–455 (2001).
   PubMed Web of Science ®Google Scholar
• Wieseler-Frank J, Maier S,Watkins L. Glial activation and pathological pain. Neurochem. Int.45, 389–395 (2004).
   PubMed Web of Science ®Google Scholar
• Kelman L. The triggers or precipitants of the acute migraine attack. Cephalalgia27, 394–402 (2007).
   PubMed Web of Science ®Google Scholar
• Selby G, Lance JW. Observations on 500 cases of migraine and allied vascular headache. J. Neurol. Neurosurg. Psychiatry23, 23–32 (1960).
   PubMed Web of Science ®Google Scholar
• Burstein R, Cutrer MF, Yarnitsky D. The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain123(Pt 8), 1703–1709 (2000).
   PubMed Web of Science ®Google Scholar
• Burstein R, Yarnitsky D, Goor-Aryeh I, Ransil BJ, Bajwa ZH. An association between migraine and cutaneous allodynia. Ann. Neurol.47(5), 614–624 (2000).
   PubMed Web of Science ®Google Scholar
• Burstein R, Collins B, Jakubowski M. Defeating migraine pain with triptans: a race against the development of cutaneous allodynia. Ann. Neurol.55(1), 19–26 (2004).
   PubMed Web of Science ®Google Scholar
• Lovati C, D’Amico D, Bertora P et al. Acute and interictal allodynia in patients with different headache forms: an Italian pilot study. Headache48(2), 272–277 (2008).
   PubMed Web of Science ®Google Scholar
• Burstein R. Deconstructing migraine headache into peripheral and central sensitization. Pain89(2–3), 107–110 (2001).
   PubMed Web of Science ®Google Scholar
• Willis WD, Coggeshall RE. Sensory Mechanisms of the Spinal Cord. Plenum Press, NY, USA, 132–148 (1991).
   Google Scholar
• Murase K, Ryu PD, Randic M. Substance P augments a persistent slow inward calcium-sensitive current in voltage-clamped spinal dorsal horn neurons of the rat. Brain Res.365(2), 369–376 (1986).
   PubMed Web of Science ®Google Scholar
• Sivilotti LG, Thompson SW, Woolf CJ. Rate of rise of the cumulative depolarization evoked by repetitive stimulation of small-caliber afferents is a predictor of action potential windup in rat spinal neurons in vitro. J. Neurophysiol.69(5), 1621–1631 (1993).
   PubMed Web of Science ®Google Scholar
• Ji RR, Kohno T, Moore KA, Woolf CJ. Central sensitization and LTP: do pain and memory share similar mechanisms? Trends Neurosci.26(12), 696–705 (2003).
   PubMed Web of Science ®Google Scholar
• Kelman L. The aura: a tertiary care study of 952 migraine patients. Cephalalgia24, 728–734 (2004).
   PubMed Web of Science ®Google Scholar
• Leao AAP. Spreading depression of activity in cerebral cortex. J. Neurophysiol.117, 199–210 (1944).
   Google Scholar
• Millner PM. Note on a possible correspondence between the scotomas of migraine and the spreading depression of Leao. Electroencephalogr. Clin. Neurophysiol.10, 705 (1959).
   Google Scholar
• Fabricius M, Fuhr S, Bhatia R et al. Cortical spreading depression and peri-infarct depolarization in acutely injured human cerebral cortex. Brain129, 778–790 (2006).
   PubMed Web of Science ®Google Scholar
• Strong AJ, Fabricius M, Boutelle MG et al. Spreading and synchronous depressions of cortical activity in acutely injured human brain. Stroke33, 2738–2743 (2002).
   PubMed Web of Science ®Google Scholar
• Mayevsky A, Doron A, Manor T et al. Cortical spreading depression recorded from the human brain using a multiparametric monitoring system. Brain Res.740, 268–274 (1996).
   PubMed Web of Science ®Google Scholar
• Dreier JP, Major S, Manning A. Cortical spreading ischaemia is a novel process involved in ischaemic damage in patients with aneurysmal subarachnoid haemorrhage. Brain132(7), 1866–1881 (2009).
   PubMed Web of Science ®Google Scholar
• Lauritzen M. Pathophysiology of the migraine aura. The spreading depression theory. Brain117, 199–210 (1994).
   PubMed Web of Science ®Google Scholar
• Lauritzen M. Cortical spreading depression in migraine. Cephalalgia21, 757–760 (2001).
   PubMed Web of Science ®Google Scholar
• Vinogradova LV, Koroleva VI, Bures J. Re-entry waves of Leao’s spreading depression between neocortex and caudate nucleus. Brain Res.538, 161–164 (1991).
   PubMed Web of Science ®Google Scholar
• Eikermann-Haerter K, Dilekoz E, Kudo C et al. Genetic and hormonal factors modulate spreading depression and transient hemiparesis in mouse models of familial hemiplegic migraine type 1. J. Clin. Invest.119, 99–109 (2009).
   PubMed Web of Science ®Google Scholar
• Olesen J, Larsen B, Lauritzen M. Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann. Neurol.9, 344–352 (1981).
   PubMed Web of Science ®Google Scholar
• Olesen J. Cerebral and extracranial circulatory disturbances in migraine: pathophysiological implications. Cerebrovas.Brain Metab. Rev.3, 1–28 (1991).
   PubMed Web of Science ®Google Scholar
• Brennan KC, Romero Reyes M, Lopez Valdes HE et al. Reduced threshold for cortical spreading depression in female mice. Ann. Neurol.61, 603–606 (2007).
   PubMed Web of Science ®Google Scholar
• Eikermann-Haerter K, Baum MJ, Ferrari MD et al. Androgenic suppression of spreading depression in amilial hemiplegic migraine type 1 mutant mice. Ann. Neurol.66, 564–568 (2009).
   PubMed Web of Science ®Google Scholar
• Ayata C, Jin H, Kudo C et al. Suppression of cortical spreading depression in migraine prophylaxis. Ann. Neurol.59, 652–661 (2006).
   PubMed Web of Science ®Google Scholar
• Buzzi MG, Bonamini M, Moskowitz MA. Neurogenic model of migraine. Cephalalgia15, 277–280 (1995).
   PubMed Web of Science ®Google Scholar
• Zhang X, Levy D, Kainz V et al. Activation of meningeal nociceptor by cortical spreading depression. Presented at: Society for Neuroscience Annual Meeting. Chicago, IL, USA, 17–21 October 2009.
   Google Scholar
• Moskowitz MA, Nozaki K, Kraig RP. Neocortical spreading depression provokes the expression of c-fos protein-like immunoreactivity within trigeminal nucleus caudalis via trigeminovascular mechanisms. J. Neurosci.13, 1167–1177 (1993).
   PubMed Web of Science ®Google Scholar
• Kunkler PE, Kraig RP. Hippocampal spreading depression bilaterally activates the caudal trigeminal nucleus in rodents. Hippocampus13, 835–844 (2003).
   PubMed Web of Science ®Google Scholar
• Charles AC, Merrill JE, Dirksen ER, Sanderson MJ. Intercellular signaling in glial cells: calcium waves and oscillations in response to mechanical stimulation and glutamate. Neuron6, 983–992 (1991).
   PubMed Web of Science ®Google Scholar
• Peters O, Schipke CG, Hashimoto Y, Kettenmann H. Different mechanisms promote astrocyte Ca2+ waves and spreading depression in the mouse neocortex. J. Neurosci.23, 9888–9896 (2003).
   PubMed Web of Science ®Google Scholar
• Basarsky TA, Duffy SN, Andrew RD, MacVicar BA. Imaging spreading depression and associated intracellular calcium waves in brain slices. J. Neurosci.18, 7189–7199 (1998).
   PubMed Web of Science ®Google Scholar
• Chuquet J, Hollender L, Nimchinsky E. High-resolution in vivo imaging of the neurovascular unit during spreading depression. J. Neurosci.27, 4036–4044 (2007).
   PubMed Web of Science ®Google Scholar
• Dohmen C, Sakowitz OW, Fabricius M et al. Spreading depolarizations occur in human ischemic stroke with high incidence. Ann. Neurol.63, 720–728 (2008).
   PubMed Web of Science ®Google Scholar
• Schumacher GA, Ray BS, Wolff HG. Experimental studies on headache. Further analysis of histamine headache and its pain pathways. Arch. Neurol. Psychiatry44, 701–717 (1940).
   Google Scholar
• Kunkle EC, Ray BS, Wolff HG. Experimental studies on headache. Arch. Neurol. Psychiatry49, 323–331 (1943).
   Google Scholar
• Davis KD, Dostrovsky JO. Activation of trigeminal brain-stem nociceptive neurons by dural artery stimulation. Pain25, 395–401 (1986).
   PubMed Web of Science ®Google Scholar
• Maciewicz R, Strassman A, Mason P, Moskowitz M. Activation of nociceptive neurons in the spinal trigeminal nucleus by stimulation of dural blood vessels. Soc. Neurosci. Abstr.12, 30 (1986).
   Google Scholar
• Lambert GA, Lowy AJ, Boers PM, Angus-Leppan H, Zagami AS. The spinal cord processing of input from the superior sagittal sinus: pathway and modulation by ergot alkaloids. Brain Res.597, 321–330 (1992).
   PubMed Web of Science ®Google Scholar
• Hoskin KL, Donaldson C, Zagami AS, Lambert GA. The 5-hydroxytryptamine1B/1D/1F receptor agonists eletriptan and naratriptan inhibit trigeminovascular input to the nucleus tractus solitarius in the cat. Brain Res.998, 91–99 (2004).
   PubMed Web of Science ®Google Scholar
• Zagami AS, Lambert GA, Lance JW. Stimulation of cranial vessels activates neurons in the thalamus of the cat. Soc. Neurosci. Abstr.14, 1164 (1988).
   Google Scholar
• Davis KD, Dostrovsky JO. Properties of feline thalamic neurons activated by stimulation of the middle meningeal artery and sagittal sinus. Brain Res.454, 89–100 (1988).
   PubMed Web of Science ®Google Scholar
• Zagami AS, Lambert GA. Thalamic neurones with craniovascular input project to somatosensory cortex in the cat. J. Clin. Neurosci.4, 412 (1997).
   Google Scholar
• Burstein R, Yamamura H, Malick A, Strassman AM. Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons. J. Neurophysiol.79, 964–982 (1998).
   PubMed Web of Science ®Google Scholar
• Kaube H, Hoskin KL, Goadsby PJ. Activation of the trigeminovascular system by mechanical distension of the superior sagittal sinus in the cat. Cephalalgia12, 133–136 (1992).
   PubMed Web of Science ®Google Scholar
• Hoskin KL, Kaube H, Goadsby PJ. Mechanical distension of the superior sagittal sinus evokes c-Fos expression in trigeminal neurons – towards a better model of migraine. Cephalagia15(Suppl. 14), 104 (1995).
   PubMed Web of Science ®Google Scholar
• Moskowitz MA, Reinhard JF Jr, Romero J, Melamed E, Pettibone DJ. Neurotransmitters and the fifth cranial nerve: is there a relation to the headache phase of migraine? Lancet2(8148), 883–885 (1979).
   PubMed Web of Science ®Google Scholar
• Moskowitz MA. Neurogenic inflammation in the pathophysiology and treatment of migraine. Neurology43(6 Suppl. 3), S16–S20 (1993).
   PubMed Web of Science ®Google Scholar
• Branchet-Gumila MC, Boisnic S, Le Charpentier Y, Nonotte I, Montastier C, Breton L. Neurogenic modifications induced by substance P in an organ culture of human skin. Skin Pharmacol. Appl. Skin Physiol.12(4), 211–220 (1999).
   PubMedGoogle Scholar
• Polley JS, Gaskin PJ, Perren MJ, Connor HE, Ward P, Beattie DT. The activity of GR205171, a potent non-peptide tachykinin NK1 receptor antagonist, in the trigeminovascular system. Regul. Pept.68(1), 23–29 (1997).
   PubMed Web of Science ®Google Scholar
• Beattie DT, Beresford IJ, Connor HE et al. The pharmacology of GR203040, a novel, potent and selective non-peptide tachykinin NK1 receptor antagonist. Br. J. Pharmacol.116(8), 3149–3157 (1995).
   PubMed Web of Science ®Google Scholar
• Hunt SP, O’Brien JA, Palmer JA. Role of substance P in nociception, analgesia, and aggression. In: Molecular Basis of Pain Induction. Wood JN (Ed.). Wiley-Liss Publishers, NY, USA, 209–260 (2000).
   Google Scholar
• Perini F, D’Andrea G, Galloni E et al. Plasma cytokine levels in migraineurs and controls. Headache45, 926–931 (2005).
   PubMed Web of Science ®Google Scholar
• Sarchielli P, Alberti A, Baldi A et al. Proinflammatory cytokines, adhesion molecules, and lymphocyte integrin expression in the internal jugular blood of migraine patients without aura assessed ictally. Headache46, 200–207 (2006).
   PubMed Web of Science ®Google Scholar
• Lamonte M, Silberstein SD, Marcelis JF. Headache associated with aseptic meningitis. Headache35, 520–526 (1995).
   PubMed Web of Science ®Google Scholar
• Levy D, Strassman AM. Distinct sensitizing effects of the cAMPPKA second messenger cascade on rat dural mechanonociceptors. J. Physiol. (Lond.)538, 483–493 (2002).
   Google Scholar
• Zhang X, Strassman AM, Burstein R, Levy D. Sensitization and activation of intracranial meningeal nociceptors by mast cell mediators. J. Pharmacol. Exp. Ther.322, 806–812 (2007).
   PubMed Web of Science ®Google Scholar
• Bove GM, Moskowitz MA. Primary afferent neurons innervating guinea pig dura. J. Neurophysiol.77, 299–308 (1997).
   PubMed Web of Science ®Google Scholar
• Levy D, Burstein R, Kainz V, Jakubowski M, Strassman AM. Mast cell degranulation activates a pain pathway underlying migraine headache. Pain130, 166–176 (2007).
   PubMed Web of Science ®Google Scholar
• Fay T. Mechanisms of headache. Arch. Neurol. Psychiatry37, 471 (1937).
   Google Scholar
• Levy D. Migraine pain and nociceptor activation – where do we stand? Headache50, 909–916 (2010).
   PubMed Web of Science ®Google Scholar
• Schmuck K, Ullmer C, Engels P, Lübbert H. Cloning and functional characterization of the human 5-HT2B serotonin receptor. FEBS Lett.42(1), 85–90 (1994).
   Google Scholar
• Humphrey PP. 5-hydroxytryptamine and the pathophysiology of migraine. J. Neurol.238(Suppl. 1), S38–S44 (1991).
   PubMed Web of Science ®Google Scholar
• Hegerl U, Juckel G. Intensity dependence of auditory evoked potentials as an indicator of central serotonergic neurotransmission: a new hypothesis. Biol. Psychiatry33(3), 173–187 (1993).
   PubMed Web of Science ®Google Scholar
• Chugani DC, Niimura K, Chaturvedi S et al. Increased brain serotonin synthesis in migraine. Neurology53(7), 1473–1479 (1999).
   PubMed Web of Science ®Google Scholar
• Ferrari MD, Saxena PR. On serotonin and migraine: a clinical and pharmacological review. Cephalalgia13(3), 151–165 (1993).
   PubMed Web of Science ®Google Scholar
• Ferrari MD, Odink J, Tapparelli C, Van Kempen GM, Pennings EJ, Bruyn GW. Serotonin metabolism in migraine. Neurology39(9), 1239–1242 (1989).
   PubMed Web of Science ®Google Scholar
• Kalkman HO. Is migraine prophylactic activity caused by 5-HT2B or 5-HT2C receptor blockade? Life Sci.54(10) 64, 1–4 (1994).
   PubMed Web of Science ®Google Scholar
• De Vries P, Villalón CM, Saxena PR. Pharmacological aspects of experimental headache models in relation to acute antimigraine therapy. Eur. J. Pharmacol.375(1–3), 61–74 (1999).
   PubMed Web of Science ®Google Scholar
• Tfelt-Hansen P, De Vries P, Saxena PR. Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy. Drugs60(6), 1259–1287 (2000).
   PubMed Web of Science ®Google Scholar
• Goadsby PJ, Hargreaves RJ. Mechanisms of action of serotonin 5-HT1B/D agonists: insights into migraine pathophysiology using rizatriptan. Neurology55(9 Suppl 2), S8–S14 (2000).
   PubMed Web of Science ®Google Scholar
• Goadsby PJ, Lipton RB, Ferrari MD. Migraine – current understanding and treatment. N. Engl. J. Med.346(4), 257–270 (2002).
   PubMed Web of Science ®Google Scholar
• Levy D, Jakubowski M, Burstein R. Disruption of communication between peripheral and central trigeminovascular neurons mediates the antimigraine action of 5HT 1B/1D receptor agonists. Proc. Natl Acad. Sci. USA101(12), 4274–4279 (2004).
   PubMed Web of Science ®Google Scholar
• Knowles RG, Moncada S. Nitric oxide synthases in mammals. Biochem. J.298(2), 249–258 (1994).
   PubMed Web of Science ®Google Scholar
• Masini E, Di Bello MG, Pistelli A et al. Generation of nitric oxide from nitrovasodilators modulates the release of histamine from mast cells. J. Physiol. Pharmacol.45(1), 41–53 (1994).
   PubMedGoogle Scholar
• Bredt DS, Snyder SH. Nitric oxide, a novel neuronal messenger. Neuron8(1), 3–11 (1992).
   PubMed Web of Science ®Google Scholar
• Fozard JR. The 5-hydroxytryptamine-nitric oxide connection: the key link in the initiation of migraine? Arch. Int. Pharmacodyn. Ther.329(1), 111–119 (1995).
   PubMedGoogle Scholar
• Garthwaite J, Charles SL, Chess-Williams R. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature336(6197), 385–388 (1988).
   PubMed Web of Science ®Google Scholar
• Glusa E, Richter M. Endothelium-dependent relaxation of porcine pulmonary arteries via 5-HT1C-like receptors. Naunyn Schmiedebergs Arch. Pharmacol.347(5), 471–477 (1993).
   PubMed Web of Science ®Google Scholar
• Gray DW, Marshall I. Human α-calcitonin gene-related peptide stimulates adenylate cyclase and guanylate cyclase and relaxes rat thoracic aorta by releasing nitric oxide. Br. J. Pharmacol.107(3), 691–696 (1992).
   PubMed Web of Science ®Google Scholar
• Luscher TF, Vanhoutte PM. The Endothelium: Modulator of Cardiovascular Functions. CRC Press, FL, USA (1990).
   Google Scholar
• Hadjikhani N, Sanchez Del Rio M, Wu O et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc. Natl Acad. Sci. USA98(8), 4687–4692 (2001).
   PubMed Web of Science ®Google Scholar
• Read SJ, Smith MI, Hunter AJ, Parsons AA. The dynamics of nitric oxide release measured directly and in real time following repeated waves of cortical spreading depression in the anaesthetised cat. Neurosci. Lett.232(3), 127–130 (1997).
   PubMed Web of Science ®Google Scholar
• Palacios J, Marusic ET, Lopez NC, Gonzalez M, Michea L. Estradiol-induced expression of N+-K+-ATPase catalytic isoforms in rat arteries: gender differences in activity mediated by nitric oxide donors. Am. J. Physiol. Heart Circ. Physiol.286(5), 1793–1800 (2004).
   Google Scholar
• Moncada S. ‘Ottorino Rossi’ Award 1997. The biology of nitric oxide. Funct. Neurol. (3–4), 134–140 (1997).
   PubMed Web of Science ®Google Scholar
• Lowenstein CJ, Dinerman JL, Snyder SH. Nitric oxide: a physiologic messenger. Ann. Intern. Med.120(3), 227–237 (1994).
   PubMed Web of Science ®Google Scholar
• Radomski MW, Zakar T, Salas E. Nitric oxide in platelets. Methods Enzymol.69, 88–107 (1996).
   Google Scholar
• Rand MJ. Nitrergic transmission: nitric oxide as a mediator of non-adrenergic, non-cholinergic neuro-effector transmission. Clin. Exp. Pharmacol. Physiol.19(3), 147–169 (1992)
   PubMed Web of Science ®Google Scholar
• Toda N, Okamura T. Mechanism underlying the response to vasodilator nerve stimulation in isolated dog and monkey cerebral arteries. Am. J. Physiol.259(5 Pt 2), H1511–H1517 (1990).
   PubMed Web of Science ®Google Scholar
• Urban MO, Gebhart GF. Supraspinal contributions to hyperalgesia. Proc. Natl Acad. Sci. USA96(14), 7687–7692 (1999).
   PubMed Web of Science ®Google Scholar
• Lepori M, Sartori C, Trueb L, Owlya R, Nicod P, Scherrer U. Haemodynamic and sympathetic effects of inhibition of nitric oxide synthase by systemic infusion of N(G)-monomethyl-L-arginine into humans are dose dependent. J. Hypertens.6(4), 519–523 (1998).
   Google Scholar
• Wei EP, Moskowitz MA, Boccalini P, Kontos HA. Calcitonin gene-related peptide mediates nitroglycerin and sodium nitroprusside-induced vasodilation in feline cerebral arterioles. Circ. Res.70(6), 1313–1319 (1992).
   PubMed Web of Science ®Google Scholar
• Sances G, Tassorelli C, Pucci E, Ghiotto N, Sandrini G, Nappi G. Reliability of the nitroglycerin provocative test in the diagnosis of neurovascular headaches. Cephalalgia24(2), 110–119 (2004).
   PubMed Web of Science ®Google Scholar
• Thomsen LL, Kruuse C, Iversen HK et al. A nitric oxide donor (nitroglycerin) triggers genuine migraine attacks. Eur. J. Neurol.1, 73–80 (1994).
   PubMed Web of Science ®Google Scholar
• Ekbom K. Nitroglycerin as a provocative agent in cluster headache. Arch. Neurol.19, 487–493 (1968).
   PubMedGoogle Scholar
• Costa A, Ravaglia S, Sances G , Antonaci F, Pucci E, Nappi G. Nitric oxide pathway and response to nitroglycerin in cluster headache patients: plasma nitrite and citrulline levels. Cephalalgia23(6), 407–413 (2003).
   PubMed Web of Science ®Google Scholar
• Ashina M, Bendtsen L, Jensen R, Sakai F, Olesen J. Possible mechanisms of glyceryl-trinitrate-induced immediate headache in patients with chronic tension-type headache. Cephalalgia20(10), 919–924 (2000).
   PubMed Web of Science ®Google Scholar
• Hansen JM, Thomsen LL, Olesen J, Ashina M. Familial hemiplegic migraine type 1 shows no hypersensitivity to nitric oxide. Cephalalgia28(5), 496–505 (2008).
   PubMed Web of Science ®Google Scholar
• Hansen JM, Thomsen LL, Marconi R, Casari G, Olesen J, Ashina M. Familial hemiplegic migraine type 2 does not share hypersensitivity to nitric oxide with common types of migraine. Cephalalgia28(4), 367–375 (2008).
   PubMed Web of Science ®Google Scholar
• Goadsby PJ, Edvinsson L, Ekman R. Release of vasoactive peptides in the extracerebral circulation of man and the cat during activation of the trigeminovascular system. Ann. Neurol.23(2), 193–196 (1988).
   PubMed Web of Science ®Google Scholar
• Goadsby PJ, Edvinsson, L. Peripheral and central trigeminovascular activation in cat is blocked by the serotonin (5HT)-1D receptor agonist 311C90. Headache34, 394–399 (1994).
   PubMed Web of Science ®Google Scholar
• Goadsby PJ, Edvinsson L. The trigeminovascular system and migraine: studies characterising cerebrovascular and neuro-peptide changes seen in man and cat. Ann. Neurol.33, 48–56 (1993).
   PubMed Web of Science ®Google Scholar
• Jansen-Olesen I, Mortensen A, Edvinsson L. Calcitonin gene-related peptide is released from capsaicin-sensitive nerve fibres and induces vasodilatation of human cerebral arteries concomitant with activation of adenylyl cyclase. Cephalalgia16(5), 310–316 (1996).
   PubMed Web of Science ®Google Scholar
• Edvinsson L, Jansen I, Kingman TA, McCulloch J. Cerebrovascular responses to capsaicin in vitro and in situ. Br. J. Pharmacol.100(2), 312–318 (1990).
   PubMed Web of Science ®Google Scholar
• Brain SD, Grant AD. Vascular actions of calcitonin gene-related peptide and adrenomedullin. Physiol. Rev.84(3), 903–934 (2004)
   PubMed Web of Science ®Google Scholar
• Gallai V, Sarchielli P, Floridi A et al. Vasoactive peptides levels in the plasma of young migraine patients with and without aura assessed both interictally and ictally. Cephalalgia15, 384–390 (1995).
   PubMed Web of Science ®Google Scholar
• Goadsby PJ, Edvinsson L, Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann. Neurol.28, 183–187 (1990).
   PubMed Web of Science ®Google Scholar
• Fanciullacci M, Alessandri M, Figini M, Geppetti P, Michelacci S. Increase in plasma calcitonin gene-related peptide from extracerebral circulation during nitroglycerin-induced cluster headache attack. Pain60, 119–123 (1995).
   PubMed Web of Science ®Google Scholar
• Goadsby PJ, Edvinsson L. Human in vivo evidence for trigeminovascular activation in cluster headache. Brain117, 427–434 (1994).
   PubMed Web of Science ®Google Scholar
• Goadsby PJ, Edvinsson L. Neuropeptide changes in a case of chronic paroxysmal hemicrania-evidence for trigemino-parasympathetic activation. Cephalalgia16, 448–450 (1996).
   PubMed Web of Science ®Google Scholar
• Lassen LH, Haderslev PA, Jacobsen VB et al. CGRP may play a causative role in migraine. Cephalalgia22, 54–61 (2002).
   PubMed Web of Science ®Google Scholar
• Hansen JM, Thomsen LL, Olesen J, Ashina M. Calcitonin gene-related peptide does not cause the familial hemiplegic migraine phenotype. Neurology71(11), 841–847 (2008).
   PubMed Web of Science ®Google Scholar
• Williamson DJ, Hargreaves RJ. Neurogenic inflammation in the context of migraine. Microsc. Res. Tech.53(3), 167–178 (2001).
   PubMed Web of Science ®Google Scholar
• Dahlöf C. Integrating the triptans into clinical practice. Curr. Opin. Neurol.15, 317–322 (2002).
   PubMed Web of Science ®Google Scholar
• Salvatore CA, Hershey JC, Corcoran HA et al. Pharmacological characterization of MK-0974 [N-[(3R, 6 S)-6-(2, 3-difluorophenyl)-2-oxo-1-(2, 2, 2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2, 3-dihydro-1Himidazo[4, 5-b]pyridin-1-yl)piperidine-1-carboxamide], a potent and orally active calcitonin gene-related peptide receptor antagonist for the treatment of migraine. J. Pharmacol. Exp Ther.324, 416–421 (2008).
   PubMed Web of Science ®Google Scholar
• Ho TW, Ferrari, MD, Dodick DW et al. Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene related peptide receptor, compared with olmitriptan for acute migraine: a randomized, placebo-controlled, parallel-treatment trial. Lancet372, 2115–2123 (2008).
   PubMed Web of Science ®Google Scholar
• Ho TW, Ferrari, MD, Dodick DW et al. Clinical profile of the novel oral CGRP receptor antagonist telcagepant for the acute treatment of migraine in two Phase 3 randomized placebo controlled trials. Neurology72, A250 (2009).
   Google Scholar
• Durham PL, Vause CV. Calcitonin gene-related peptide (CGRP) receptor antagonists in the treatment of migraine. CNS Drugs24(7), 539–548 (2010).
   PubMed Web of Science ®Google Scholar
• Yu LC, Hou JF, Fu FH, Zhang YX. Roles of calcitonin gene-related peptide and its receptors in pain-related behavioral responses in the central nervous system. Neurosci. Biobehav. Rev.33(8), 1185–1191 (2009).
   PubMed Web of Science ®Google Scholar
• Schorscher-Petcu A, Austin JS, Mogil JS, Quirion R. Role of central calcitonin gene-related peptide (CGRP) in locomotor and anxiety- and depression-like behaviors in two mouse strains exhibiting a CGRP-dependent difference in thermal pain sensitivity. J. Mol. Neurosci.39(1–2), 125–136 (2009).
   PubMed Web of Science ®Google Scholar
• Borsook D, DaSilva AF, Ploghaus A, Becerra L. Specific and somatotopic functional magnetic resonance imaging activation in the trigeminal ganglion by brush and noxious heat. J. Neurosci.23(21), 7897–7903 (2003).
   PubMed Web of Science ®Google Scholar
• Hsieh JC, Ståhle-Bäckdahl M, Hägermark O, Stone-Elander S, Rosenquist G, Ingvar M. Traumatic nociceptive pain activates the hypothalamus and the periaqueductal gray: a positron emission tomography study. Pain64(2), 303–314 (1996).
   PubMed Web of Science ®Google Scholar
• Tracey I, Ploghaus A, Gati JS et al. Imaging attentional modulation of pain in the periaqueductal gray in humans. J. Neurosci.22(7), 2748–2752 (2002).
   PubMed Web of Science ®Google Scholar
• Petrovic P, Kalso E, Petersson KM, Ingvar M. Placebo and opioid analgesia – imaging a shared neuronal network. Science295(5560), 1737–1740 (2002)
   PubMed Web of Science ®Google Scholar
• Wager TD, Rilling JK, Smith EE et al. Placebo-induced changes in FMRI in the anticipation and experience of pain. Science303(5661), 1162–1167 (2004).
   PubMed Web of Science ®Google Scholar
• Ploghaus A, Tracey I, Gati JS et al. Dissociating pain from its anticipation in the human brain. Science284(5422), 1979–1981 (1999).
   PubMed Web of Science ®Google Scholar
• Petrovic P, Petersson KM, Ghatan PH, Stone-Elander S, Ingvar M. Pain-related cerebral activation is altered by a distracting cognitive task. Pain (1–2), 19–30 (2000).
   PubMedGoogle Scholar
• Bantick SJ, Wise RG, Ploghaus A, Clare S, Smith SM, Tracey I. Imaging how attention modulates pain in humans using functional MRI. Brain125(Pt 2), 310–319 (2002).
   PubMed Web of Science ®Google Scholar
• Longe SE, Wise R, Bantick S et al. Counter-stimulatory effects on pain perception and processing are significantly altered by attention: an fMRI study. Neuroreport12(9), 2021–2025 (2001)
   PubMed Web of Science ®Google Scholar
• Hsieh JC, Hannerz J, Ingvar M. Right-lateralised central processing for pain of nitroglycerin-induced cluster headache. Pain67(1), 59–68 (1996).
   PubMed Web of Science ®Google Scholar
• Jones AK, Kulkarni B, Derbyshire SW. Pain mechanisms and their disorders. Br. Med. Bull.65, 83–93 (2003).
   PubMed Web of Science ®Google Scholar
• Peyron R. Laurent B, Garcia-Larrea L. Functional imaging of brain responses to pain. A review and meta-analysis. Neurophysiol. Clin.30, 263–288 (2000).
   PubMed Web of Science ®Google Scholar
• Valet M. Sprenger T. Boecker H et al. Distraction modulates connectivity of the cingulo-frontal cortex and the midbrain during pain – an fMRI analysis. Pain109, 399–408 (2004).
   PubMed Web of Science ®Google Scholar
• Schoonman GG, van der Grond J, Kortmann C, van der Geest RJ, Terwindt GM, Ferrari MD. Migraine headache is not associated with cerebral or meningeal vasodilatation – a 3T magnetic resonance angiography study. Brain131, 2192–2200 (2008).
   PubMed Web of Science ®Google Scholar
• Nagata E, Moriguchi H, Takizawa S, Horie T, Yanagimachi N, Takagi S. The middle meningial artery during a migraine attack: 3T magnetic resonance angiography study. Intern. Med.48, 2133–2135 (2009).
   PubMed Web of Science ®Google Scholar
• Nedergaard M, Ransom B, Goldman SA. New roles for astrocytes: redefining the functional architecture of the brain. Trends Neurosci.26(10), 523–530 (2003).
   PubMed Web of Science ®Google Scholar
• Woods RP, Iacoboni M, Mazziotta JC. Brief report: bilateral spreading cerebral hypoperfusion during spontaneous migraine headache. N. Engl. J. Med.331, 1689–1692 (1994).
   PubMed Web of Science ®Google Scholar
• Denuelle M, Fabre N, Payoux P et al. Posterior cerebral hypoperfusion in migraine without aura. Cephalalgia28, 856–862 (2008).
   PubMed Web of Science ®Google Scholar
• Chalaupka FD. Reversible imaging abnormalities consistent with CSD during migraine without aura attack. Headache48(8), 1229–1232 (2008).
   PubMed Web of Science ®Google Scholar
• May A, Kaube H, Buchel C et al. Experimental cranial pain elicited by capsaicin: a PET study. Pain74, 61–66 (1998)
   PubMed Web of Science ®Google Scholar
• Afridi SK, Giffin NJ, Kaube H et al. A positron emission tomographic study in spontaneous migraine. Arch. Neurol.62, 1270–1275 (2005).
   PubMedGoogle Scholar
• Afridi SK, Matharu MS, Lee L et al. A PET study exploring the laterality of brainstem activation in migraine using glyceryl trinitrate. Brain128, 932–939 (2005).
   PubMed Web of Science ®Google Scholar
• Denuelle M, Fabre N, Payoux P et al. Hypothalamic activation in spontaneous migraine attacks. Headache47, 1418–1426 (2007).
   PubMed Web of Science ®Google Scholar
• Bahra A, Matharu MS, Buchel C et al. Brainstem activation specific to migraine headache. Lancet357, 1016–1017 (2001).
   PubMed Web of Science ®Google Scholar
• Matharu MS, Bartsch T, Ward N et al. Central neuromodulation in chronic migraine patients with suboccipital stimulators: a PET study. Brain127, 220–230 (2004).
   PubMed Web of Science ®Google Scholar
• Sanchez del Rio M, Bakker D, Wu O et al. Perfusion weighted imaging during migraine: spontaneous visual aura and headache. Cephalalgia19, 701–707 (1999).
   PubMed Web of Science ®Google Scholar
• Cao,Y, Welch KM, Aurora S et al. Functional MRI-BOLD of visually triggered headache in patients with migraine. Arch. Neurol56, 548–554 (1999).
   PubMed Web of Science ®Google Scholar
• Lance JW, Lambert GA, Goadsby PJ et al. Brainstem influences on the cephalic circulation: experimental data from cat and monkey of relevance to the mechanism of migraine. Headache23, 258–265 (1983).
   PubMed Web of Science ®Google Scholar
• Goadsby PJ, Duckworth JW. Low frequency stimulation of the locus coeruleus reduces regional cerebral blood flow in the spinalized cat. Brain Res.476, 71–77 (1989).
   PubMed Web of Science ®Google Scholar
• May A, Bahra A, Buchel C et al. Hypothalamic activation in cluster headache attacks. Lancet352, 275–278 (1998).
   PubMed Web of Science ®Google Scholar
• Sprenger T, Boecker H, Tolle TR et al. Specific hypothalamic activation during a spontaneous cluster headache attack. Neurology62, 516–517 (2004).
   PubMed Web of Science ®Google Scholar
• Lodi R, Pierangeli G, Tonon C et al. Study of hypothalamic metabolism in cluster headache by proton MR spectroscopy. Neurology66, 1264–1266 (2006).
   PubMed Web of Science ®Google Scholar
• Wang SJ, Lirng JF, Fuh JL et al. Reduction in hypothalamic 1H-MRS metabolite ratios in patients with cluster headache. J. Neurol. Neurosurg. Psychiatry77, 622–625 (2006).
   PubMed Web of Science ®Google Scholar
• Leone M, Proietti A, Cecchini AP et al. Lessons from 8 years’ experience of hypothalamic stimulation in cluster headache. Cephalalgia28, 787–797 (2008).
   PubMed Web of Science ®Google Scholar
• Sprenger T, Berthele A, Platzer S et al. What to learn from in vivo opioidergic brain imaging? Eur. J. Pain9, 117–121 (2005).
   PubMed Web of Science ®Google Scholar
• May A, Bahra A, Buchel C et al. Functional magnetic resonance imaging in spontaneous attacks of SUNCT: short-lasting neuralgiform headache with conjunctival injection and tearing. Ann. Neurol.46, 791–794 (1999).
   PubMed Web of Science ®Google Scholar
• Matharu MS, Cohen AS, Frackowiak RS et al. Posterior hypothalamic activation in paroxysmal hemicrania. Ann. Neurol.59, 535–545 (2006).
   PubMed Web of Science ®Google Scholar
• May A. Morphing voxels: the hype around structural imaging of headache patients. Brain132(6), 1419–1425 (2009).
   PubMed Web of Science ®Google Scholar
• Kuchinad A, Schweinhardt P, Seminowicz DA, Wood PB, Chizh BA, Bushnell MC. Accelerated brain grey matter loss in fibromyalgia patients: premature aging of the brain? J. Neurosci.27, 4004–4007 (2007).
   PubMed Web of Science ®Google Scholar
• Davis KD, Pope G, Chen J, Kwan CL, Crawley AP, Diamant NE. Cortical thinning in IBS: implications for homeostatic, attention, and pain processing. Neurology70, 153–154 (2008).
   PubMed Web of Science ®Google Scholar
• Draganski B, Moser T, Lummel N et al. Decrease of thalamic grey matter following limb amputation. Neuroimage31, 951–957 (2006)
   PubMed Web of Science ®Google Scholar
• Apkarian AV, Sosa Y, Sonty S et al. Chronic back pain is associated with decreased prefrontal and thalamic grey matter density. J. Neurosci.24, 10410–10415 (2004).
   PubMed Web of Science ®Google Scholar
• Schmidt-Wilcke T, Leinisch E, Ganssbauer S et al. Affective components and intensity of pain correlate with structural differences in grey matter in chronic back pain patients. Pain125, 89–97 (2006).
   PubMed Web of Science ®Google Scholar
• Wrigley PJ, Gustin SM, Macey PM et al. Anatomical changes in human motor cortex and motor pathways following complete thoracic spinal cord injury. Cereb. Cortex19, 224–232 (2008).
   PubMed Web of Science ®Google Scholar
• Draganski B, Gaser C, Busch V, Schuierer G, Bogdahn U, May A. Neuroplasticity: changes in grey matter induced by training. Nature427, 311–312 (2004).
   PubMed Web of Science ®Google Scholar
• Mendola JD, Conner IP, Roy A et al. Voxel-based analysis of MRI detects abnormal visual cortex in children and adults with amblyopia. Hum. Brain Mapp.25, 222–236 (2005).
   PubMed Web of Science ®Google Scholar
• Chan ST, Tang KW, Lam KC, Chan LK, Mendola JD, Kwong KK. Neuroanatomy of adult strabismus: a voxel-based morphometric analysis of magnetic resonance structural scans. Neuroimage22, 986–994 (2004).
   PubMed Web of Science ®Google Scholar
• Draganski B, May A. Training-induced structural changes in the adult human brain. Behav. Brain Res.192, 137–142 (2008).
   PubMed Web of Science ®Google Scholar
• Teutsch S, Herken W, Bingel U, Schoell E, May A. Changes in brain grey matter due to repetitive painful stimulation. Neuroimage42, 845–849 (2008).
   PubMed Web of Science ®Google Scholar
• Rocca MA, Ceccarelli A, Falini A et al. Brain grey matter changes in migraine patients with T2-visible lesions: a 3-T MRI study. Stroke37, 1765–1770 (2006).
   PubMed Web of Science ®Google Scholar
• Kim JH, Suh SI, Seol HY et al. Regional grey matter changes in patients with migraine: a voxel-based morphometry study. Cephalalgia28, 598–604 (2008).
   PubMed Web of Science ®Google Scholar
• Valfre W, Rainero I, Bergui M, Pinessi L. Voxel-based morphometry reveals grey matter abnormalities in migraine. Headache48, 109–117 (2008).
   PubMed Web of Science ®Google Scholar
• Welch KM, Nagesh V. Aurora SK et al. Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness? Headache41, 629–637 (2001).
   PubMed Web of Science ®Google Scholar
• May A. Hypothalamic deep-brain stimulation: target and potential mechanism for the treatment of cluster headache. Cephalalgia28, 799–803 (2008).
   PubMed Web of Science ®Google Scholar
• Leone M, Franzini A, Bussone G. Stereotactic stimulation of posterior hypothalamic grey matter in a patient with intractable cluster headache. N. Engl. J. Med.345, 1428–1429 (2001).
   PubMed Web of Science ®Google Scholar
• Holle D, Naegel S, Gaul C, Krebs S, Gizewski ER. Structural and functional changes in hypnic headache. Cephalalgia29, 2 (2009).
   Google Scholar
• Schmidt-Wilcke T, Leinisch E, Straube A et al. Grey matter decrease in patients with chronic tension type headache. Neurology65, 1483–1486 (2005).
   PubMed Web of Science ®Google Scholar
• Golla FL, Winter AL. Analysis of cerebral responses to flicker in patients complaining of episodic headache. Electroencephalogr. Clin. Neurophysiol. Suppl.11, 539–549 (1959).
   Google Scholar
• Gantenbein AR, Goadsby PJ, Kaube H. Chirp stimulation – H-response short and dynamic. Cephalalgia25, 1196–1197 (2005).
   Google Scholar
• Chorlton P, Kane N. Investigation of the cerebral response to flicker stimulation in patients with neurological headache. Clin. Electroencephalogr.31, 83–87 (2000).
   PubMedGoogle Scholar
• Diener HC, Scholz E, Dichgans J et al. Central effects of drugs used in migraine prophylaxis evaluated by visual evoked potentials. Ann. Neurol.25, 125–130 (1989).
   PubMed Web of Science ®Google Scholar
• Siniatchkin M, Kropp P, Gerber WD. What kind of habituation is impaired in migraine patients? Cephalalgia23, 511–518 (2003).
   PubMed Web of Science ®Google Scholar
• Judit A, Sandor PS, Schoenen J. Habituation of visual and intensity dependence of auditory evoked cortical potentials tends to normalize just before and during the migraine attack. Cephalalgia20, 714–719 (2000).
   PubMed Web of Science ®Google Scholar
• Ambrosini A, Rossi P, DePasqua V, Pierelli F, Schoenen J. Lack of habituation causes high intensity dependence of auditory evoked cortical potentials in migraine. Brain126(Pt 9), 2009–2015 (2003).
   PubMed Web of Science ®Google Scholar
• Wang W, Timsit-Berthier M, Schoenen J. Intensity dependence of auditory evoked potentials is pronounced in migraine: an indication of cortical potentiation and low serotonergic neurotransmission? Neurology46, 1404–1409 (1996).
   PubMed Web of Science ®Google Scholar
• de Tommaso M, Libro G, Guido M, Losito L, Lamberti P, Livrea P. Habituation of single CO2 laserevoked responses during interictal phase of migraine. J. Headache Pain6, 195–198 (2005).
   PubMedGoogle Scholar
• Evers S, Bauer B, Grotemeyer KH, Kurlemann G, Husstedt IW. Event-related potentials (P300) in primary headache in childhood and adolescence. J. Child Neurol.13, 322–326 (1998).
   PubMed Web of Science ®Google Scholar
• Wang W, Schoenen J. Interictal potentiation of passive ‘oddball’ auditory event-related potentials in migraine. Cephalalgia18, 261–265 (1998).
   PubMed Web of Science ®Google Scholar
• Sandor PS, Afra J, Proietti-Cecchini A, Albert A, Schoenen J. Familial influences on cortical evoked potentials in migraine. Neuroreport10, 1235–1238 (1999).
   PubMed Web of Science ®Google Scholar
• Siniatchkin M, Kropp P, Neumann M, Gerber W, Stephani U. Intensity dependence of auditory provoked potentials in migraine families. Pain85, 247–254 (2000).
   PubMed Web of Science ®Google Scholar
• Coppola G, Pierelli F, Schoenen J. Habituation and migraine. Neurobiol. Learn. Mem.92, 249–259 (2009).
   PubMed Web of Science ®Google Scholar
• Katsarava Z, Lehnerdt G, Duda B, Ellrich J, Diener HC, Kaube H. Sensitization of trigeminal nociception specific for migraine but not pain of sinusitis. Neurology59, 1450–1453 (2002).
   PubMed Web of Science ®Google Scholar
• Katsarava Z, Giffin N, Diener HC, Kaube H. Abnormal habituation of ‘nociceptive’ blink reflex in migraine – evidence for increased excitability of trigeminal nociception. Cephalalgia23, 814–819 (2003).
   PubMed Web of Science ®Google Scholar
• de Tommaso M. Laser-evoked potentials in primary headaches and cranial neuralgias. Expert Rev. Neurother.8(9), 1339–1345 (2008).
   PubMed Web of Science ®Google Scholar
• Aurora SK, Ahmad BK, Welch KM, Bhardhwaj P, Ramadan NM. Transcranial magnetic stimulation confirms hyperexcitability of occipital cortex in migraine. Neurology50, 1111–1114 (1998).
   PubMed Web of Science ®Google Scholar
• Mulleners WM, Chronicle EP, Palmer JE, Koehler PJ, Vredeveld JW. Visual cortex excitability in migraine with and without aura. Headache41, 565–572 (2001).
   PubMed Web of Science ®Google Scholar
• Mulleners WM, Chronicle EP, Palmer JE, Koehler PJ, Vredeveld JW. Suppression of perception in migraine: evidence for reduced inhibition in the visual cortex. Neurology56, 178–183 (2001)
   PubMed Web of Science ®Google Scholar
• Aurora SK, Chronicle EP. Migraine’s magnetic attraction. Lancet Neurol.1, 211 (2002).
   PubMed Web of Science ®Google Scholar
• Battelli L, Black KR, Wray SH. Transcranial magnetic stimulation of visual area V5 in migraine. Neurology58, 1066–1069 (2002).
   PubMed Web of Science ®Google Scholar
• Antal A, Arlt S, Nitsche MA, Chadaide Z, Paulus W. Higher variability of phosphene thresholds in migraineurs than in controls: a consecutive transcranial magnetic stimulation study. Cephalalgia26, 865–870 (2006).
   PubMed Web of Science ®Google Scholar
• Afra J, Mascia A, Gerard P, Maertens de Noordhout A, Schoenen J. Interictal cortical excitability in migraine: a study using transcranial magnetic stimulation of motor and visual cortices. Ann. Neurol.44, 209–215 (1998).
   PubMed Web of Science ®Google Scholar
• Bohotin V, Fumal A, Vandenheede M, Bohotin C, Schoenen J. Excitability of visual V1–V2 and motor cortices to single transcranial magnetic stimuli in migraine: a reappraisal using a figure-of-eight coil. Cephalalgia23, 264–270 (2003).
   PubMed Web of Science ®Google Scholar
• Coppola G, Vandenheede M, Di Clemente L et al. Somatosensory evoked high-frequency oscillations reflecting thalamo-cortical activity are decreased in migraine patients between attacks. Brain128, 98–103 (2005).
   PubMed Web of Science ®Google Scholar
• Pichiecchio A, Bastianello S, Ghiotto N et al. An fMRI time and space spread post-analysis of the visual cortex in migraine with aura: preliminary results. Cephalalgia27(621), B074 (2007).
   Google Scholar
• Aurora S, Kori S, Barrodale P, Nelsen A, McDonald S. Gastric stasis occurs in spontaneous, visually induced, and interictal migraine. Headache47(10), 1443–1446 (2007).
   PubMed Web of Science ®Google Scholar
• Aurora SK, Kori SH, Barrodale P, McDonald SA, Haseley D. Gastric stasis in migraine: more than just a paroxysmal abnormality during a migraine attack. Headache46(1), 57–63 (2006).
   PubMed Web of Science ®Google Scholar
• Ashkenazi A, Mushtaq A, Yang I, Oshinsky ML. Ictal and interictal phonophobia in migraine-a quantitative controlled study. Cephalalgia (10), 1042–1048 (2009).
   PubMed Web of Science ®Google Scholar
• de Tommaso M, Sciruicchio V, Guido M, Sasanelli G, Specchio LM, Puca FM. EEG spectral analysis in migraine without aura attacks. Cephalalgia18, 324–328 (1998).
   PubMed Web of Science ®Google Scholar
• Schoenen J, Jamart B, Delwaide PJ. Electroencephalographic mapping in migraine during the headache. Rev. Electroencephalogr. Neurophysiol. Clin.17, 289–299 (1987).
   PubMedGoogle Scholar
• Kropp P, Gerber WD. Contingent negative variation during migraine attack and interval: evidence for normalization of slow cortical potentials during the attack. Cephalalgia15(2), 123–128; discussion 78–79 (1995).
   PubMed Web of Science ®Google Scholar
• Kropp P, Gerber WD. Prediction of migraine attacks using a slow cortical potential, the contingent negative variation. Neurosci. Lett.257, 73–76 (1998).
   PubMed Web of Science ®Google Scholar
• Siniatchkin M, Gerber WD, Kropp P, Vein A. How the brain anticipates an attack: a study of neurophysiological periodicity in migraine. Funct. Neurol.14, 69–77 (1999).
   PubMed Web of Science ®Google Scholar
• Holroyd KA, France JL, Nash JM, Hursey K. Pain state as artifact in the psychological assessment of recurrent headache sufferers. Pain53(2), 229–235 (1993).
   PubMed Web of Science ®Google Scholar
• Jensen R. Pathophysiological mechanisms of tension-type headache: a review of epidemiological and experimental studies. Cephalalgia19(6), 602–621 (1999).
   PubMed Web of Science ®Google Scholar
• Lipchik GL, Holroyd KA, O’Donnell FJ et al. Exteroceptive suppression periods and pericranial muscle tenderness in chronic tension-type headache: effects of psychopathology, chronicity and disability. Cephalalgia20(7), 638–646 (2000).
   PubMed Web of Science ®Google Scholar
• Bendtsen L. Central sensitization in tension-type headache – possible pathophysiological mechanisms. Cephalalgia20(5), 486–508 (2000).
   PubMed Web of Science ®Google Scholar
• Langemark M, Bach FW, Jensen TS, Olesen J. Decreased nociceptive flexion reflex threshold in chronic tension-type headache. Arch. Neurol.50(10), 1061–1064 (1993).
   PubMedGoogle Scholar
• Schoenen J, Bottin D, Hardy F, Gerard P. Cephalic and extracephalic pressure pain thresholds in chronic tension-type headache. Pain47(2), 145–149 (1991).
   PubMed Web of Science ®Google Scholar
• Ashina M. Neurobiology of chronic tension-type headache. Cephalalgia24(3), 161–172 (2004).
   PubMed Web of Science ®Google Scholar
• Sarchielli P, Alberti A, Floridi A, Gallai V. L-Arginine/nitric oxide pathway in chronic tension-type headache: relation with serotonin content and secretion and glutamate content. Neurol. Sci.15, 198(1–2), 9–15 (2002).
   Google Scholar
• Lipton RB, Cady RK, Stewart WF, Wilks K, Hall C. Diagnostic lessons from the spectrum study. Neurology58(9 Suppl. 6), S27–S31 (2002).
   Web of Science ®Google Scholar
• Cady RK, Lipton RB, Hall C, Stewart WF, O’Quinn S, Gutterman D. Treatment of mild headache in disabled migraine sufferers: results of the Spectrum Study. Headache40(10), 792–797 (2000).
   PubMed Web of Science ®Google Scholar
• Cady R, Schreiber C, Farmer K, Sheftell F. Primary headaches: a convergence hypothesis. Headache42(3), 204–216 (2002).
   PubMed Web of Science ®Google Scholar